Archives

Energy Transition Minerals Ltd (ASX: ETM) has completed its acquisition of the Penouta Tin-Tantalum-Niobium mine in north-west Spain, advancing the company's strategy to become a European critical minerals producer. The company is now progressing its application for a new exploitation concession for Section C, with detailed operational reviews scheduled for completion by the end of 2026 and environmental and social studies due in the first half of 2027. This milestone represents a significant step toward recommencing mining operations at the asset.

• July 21, 2026 09:15 AM AEST
• Mukul

Streamplay Studio Limited (ASX: SP8) has announced that Winter Burrow, its flagship title published by wholly owned subsidiary Noodlecake Studios, has reached approximately A$5.7 million in cumulative gross revenue since launching in November 2025. The cozy woodland survival game, developed by Danish indie studio Pine Creek Games, is now expanding onto Apple App Store and Google Play mobile storefronts with a targeted release date of 30 September 2026, marking a significant commercial milestone and strategic platform diversification for the ASX-listed gaming company.

• July 21, 2026 09:15 AM AEST
• Mukul

Dundas Minerals Limited (ASX: DUN) has received Aboriginal heritage clearance over its Capricorn Gold Project in Western Australia, removing a key regulatory hurdle for the company's planned drilling programme. The archaeological and ethnographic survey was completed with the Kapurn Kalamaia Karlaku Traditional Owners and returned clear findings, with no Aboriginal heritage places recorded and no areas identified as unsuitable for proposed works. With government approvals already in place, Dundas is now positioned to commence drilling across three Kalgoorlie district gold projects as part of its exploration strategy in the region.

• July 21, 2026 09:15 AM AEST
• Mukul

Beamtree Holdings Limited (ASX: BMT), a leading provider of AI decision support and data insights solutions for healthcare providers globally, has announced the resignation of Chief Financial Officer Michelle Spiller effective 24 July 2026. The board has appointed Neil Thompson as Acting Chief Financial Officer while the company undertakes a search for a permanent replacement. The departure comes as the ASX-listed healthcare technology firm continues to deliver analytics solutions across diagnostic technology, clinical decision support, coding assistance, and analytics platforms.

• July 21, 2026 09:15 AM AEST
• Mukul

State Street Global Advisors, Australia Services Limited has released its daily fund update for the State Street SPDR S&P/ASX 200 ETF (STW), providing a comprehensive snapshot of the fund's composition and valuation as of 20 July 2026. The update discloses the net asset value per unit, the index basket composition across 200 Australian and international-listed stocks, and the fund's total assets under management. Investors tracking this major Australian equity ETF will find detailed information on the current holdings and fund performance metrics in this regular disclosure.

• July 21, 2026 09:15 AM AEST
• Shwetambri Chauhan

News Corporation (NWS) has notified the ASX of ongoing repurchases under its US$1 billion share buyback program authorised in July 2025, with the company acquiring significant volumes of Class A and Class B common stock in recent trading sessions. The media and information services company, which operates major publishing, broadcasting, and digital properties globally, conducted substantial buybacks totalling over US$130 million in cumulative purchases as it seeks to enhance shareholder value through capital management. The daily buyback notification filed on 21 July 2026 reveals the company is actively executing its repurchase strategy in the open market through Goldman Sachs & Co. LLC as broker.

• July 21, 2026 09:15 AM AEST
• Shwetambri Chauhan

Cosmo Metals Limited (ASX: CMO) has released an investor presentation outlining its exploration mission focused on discovering significant orebodies within established mineral provinces. The company operates exploration projects in known geological regions, applying systematic exploration methodologies to identify mineral resources. The presentation, dated July 2026, provides background on CMO's project portfolio and operational approach to mineral discovery.

• July 21, 2026 09:15 AM AEST
• Shwetambri Chauhan

Life360, Inc. (ASX: 360, NASDAQ: LIF), the San Francisco Bay Area-based family safety and connection platform, has disclosed that a company director completed a stock transaction on the NASDAQ under a pre-established Rule 10b5-1 trading plan. The transaction, executed on 16 July 2026, involved the exercise of stock options and subsequent sale of shares to cover exercise costs and tax obligations. The sale was conducted pursuant to a written trading plan adopted in December 2025 at a time when the reporting person held no material non-public information about the company.

• July 21, 2026 09:15 AM AEST
• Shwetambri Chauhan

ClearVue Technologies Limited (ASX: CPV), an Australian smart building materials company, has successfully closed its Share Purchase Plan (SPP) with strong shareholder support, raising $1.29 million—exceeding its initial $1 million target. The company issued 14.67 million shares at $0.088 per share and will issue a 1-for-1 free attaching option to recipients, pending shareholder approval at an upcoming General Meeting. The oversubscription reflects investor confidence in ClearVue's strategy and its expanding global project pipeline in solar-integrated building technology.

• July 21, 2026 09:15 AM AEST
• Shwetambri Chauhan

CLINUVEL PHARMACEUTICALS LIMITED (ASX: CUV) has completed the transition of its American Depositary Share (ADS) to Nasdaq, with trading commencing on 20 July 2026 (New York time) under the ticker symbol CUVL. The Melbourne-based biopharmaceutical company has upgraded from its previous Level I American Depositary Receipt structure, strengthening its access to US capital markets. The move represents a significant milestone for the developer of SCENESSE®, the world's first systemic photoprotective therapy for erythropoietic protoporphyria.

• July 21, 2026 09:15 AM AEST
• Shwetambri Chauhan